-
1
-
-
0022559251
-
b, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines
-
b, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines. Cancer Res., 46: 1553-1561, 1986.
-
(1986)
Cancer Res.
, vol.46
, pp. 1553-1561
-
-
Sakamoto, J.1
Furakawa, K.2
Cordon-Cardo, C.3
Yin, B.T.W.4
Rettig, W.J.5
Oettgen, H.F.6
Old, L.J.7
Lloyd, K.O.8
-
2
-
-
0002995958
-
General concept of tumor-associated carbohydrate antigens: Their chemical, physical and enzymatic basis
-
H. F. Oettgen (ed.), Weinheim, Germany, VHC Publishers
-
Hakomori, S. General concept of tumor-associated carbohydrate antigens: their chemical, physical and enzymatic basis. In: H. F. Oettgen (ed.), Gangliosides and Cancer, pp. 93-102. Weinheim, Germany, VHC Publishers, 1989.
-
(1989)
Gangliosides and Cancer
, pp. 93-102
-
-
Hakomori, S.1
-
4
-
-
0029931120
-
y) blood group antigen expression in epithelial ovarian cancer
-
y) blood group antigen expression in epithelial ovarian cancer. Int. J. Cancer, 65: 406-412, 1996.
-
(1996)
Int. J. Cancer
, vol.65
, pp. 406-412
-
-
Yin, B.W.T.1
Finstad, C.L.2
Kitamura, K.3
Federici, M.G.4
Welshinger, M.5
Kudryashov, V.6
Hoskins, W.J.7
Welt, S.8
Lloyd, K.O.9
-
5
-
-
0030765682
-
Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group related antigens
-
Zhang, S., Zhang, H. S., Cordon-Cardo, C., Reuter, V. E., Singhal, A. K., Lloyd K. O., and Livingston P. O. Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group related antigens. Int. J. Cancer, 73: 50-56, 1997.
-
(1997)
Int. J. Cancer
, vol.73
, pp. 50-56
-
-
Zhang, S.1
Zhang, H.S.2
Cordon-Cardo, C.3
Reuter, V.E.4
Singhal, A.K.5
Lloyd, K.O.6
Livingston, P.O.7
-
6
-
-
0028609075
-
y determinants
-
y determinants. Proc. Natl. Acad. Sci. USA, 91: 12957-12961, 1994.
-
(1994)
Proc. Natl. Acad. Sci. USA
, vol.91
, pp. 12957-12961
-
-
Kitamura, K.1
Stockert, E.2
Garin-Chesa, P.3
Welt, S.4
Lloyd, K.O.5
Armour, K.L.6
Wallace, T.P.7
Harris, W.J.8
Carr, F.J.9
Old, L.J.10
-
7
-
-
0022930312
-
y blood group-related antigens in human malignant, premalignant, and non-malignant colonic tissues
-
y blood group-related antigens in human malignant, premalignant, and non-malignant colonic tissues. Cancer Res., 46: 5985-5992, 1986.
-
(1986)
Cancer Res.
, vol.46
, pp. 5985-5992
-
-
Kim, Y.S.1
Yuan, M.2
Itzkowitz, S.H.3
Sun, Q.B.4
Kaizu, T.5
Palekar, A.6
Trump, B.F.7
Hakomori, S.8
-
9
-
-
0027336494
-
111In-labeled B3 monoclonal antibody: Biodistribution and imaging studies in nude mice bearing human epidermoid carcinoma xenografts
-
111In-labeled B3 monoclonal antibody: biodistribution and imaging studies in nude mice bearing human epidermoid carcinoma xenografts. Cancer Res., 53: 2834-2839, 1993.
-
(1993)
Cancer Res.
, vol.53
, pp. 2834-2839
-
-
Camera, L.1
Kinuya, S.2
Pai, L.H.3
Garmestani, K.4
Brechbiel, M.W.5
Gansow, O.A.6
Paik, C.H.7
Pastan, I.8
Carrasquillo, J.A.9
-
10
-
-
0025126474
-
Analysis of the fine specificities of eleven mouse monoclonal antibodies reactive with type 2 blood group determinants
-
Furukawa, K., Welt, S., Yin, B. W. T., Feickert, H-J., Takahashi, T., Ueda, R., and Lloyd, K. O. Analysis of the fine specificities of eleven mouse monoclonal antibodies reactive with type 2 blood group determinants. Mol. Immunol., 27: 723-732, 1990.
-
(1990)
Mol. Immunol.
, vol.27
, pp. 723-732
-
-
Furukawa, K.1
Welt, S.2
Yin, B.W.T.3
Takahashi, T.4
Ueda, R.5
Lloyd, K.O.6
-
11
-
-
0000799375
-
y) monoclonal antibody (mAb) BR55-2 (IgG2a) in patients with advanced breast cancer
-
y) monoclonal antibody (mAb) BR55-2 (IgG2a) in patients with advanced breast cancer. Proc. Am. Soc. Clin. Oncol., 13: 299, 1994.
-
(1994)
Proc. Am. Soc. Clin. Oncol.
, vol.13
, pp. 299
-
-
Theodoulou, M.1
Gilewski, T.A.2
Welt, S.3
Garin-Chesa, P.4
Stockert, E.5
Kitamura, K.6
Steplewski, Z.7
Koprowski, H.8
Norton, I.9
Old, L.J.10
-
12
-
-
0026575769
-
Phase I/II study of monoclonal antibody against Lewis Y hapten in relapsed small-cell lung cancer
-
Stahel, R. A., Lacroix, H., Sculier, J. P., Morant, R., Richner, E., Janzek, E., Loibner, H., and Blythman, H. Phase I/II study of monoclonal antibody against Lewis Y hapten in relapsed small-cell lung cancer. Ann. Oncol., 3: 319-320, 1992.
-
(1992)
Ann. Oncol.
, vol.3
, pp. 319-320
-
-
Stahel, R.A.1
Lacroix, H.2
Sculier, J.P.3
Morant, R.4
Richner, E.5
Janzek, E.6
Loibner, H.7
Blythman, H.8
-
13
-
-
0032975042
-
Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancer
-
Tolcher, A. W., Sugarman, S., Gelmon, K. A., Cohen, R., Saleh, M., Isaacs, C., Young, L., Healey, D., Onetto, N., and Slichenmyer, W. Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancer. J Clin. Oncol., 17: 478-484, 1999.
-
(1999)
J Clin. Oncol.
, vol.17
, pp. 478-484
-
-
Tolcher, A.W.1
Sugarman, S.2
Gelmon, K.A.3
Cohen, R.4
Saleh, M.5
Isaacs, C.6
Young, L.7
Healey, D.8
Onetto, N.9
Slichenmyer, W.10
-
14
-
-
0343396311
-
Monoclonal Lewis Y antibody depletes metastatic breast carcinoma cells from bone marrow
-
Schlimok, G., Fackler-Schwalbe, I., Pantel, K., Loibner, H., and Riethmüller, G. Monoclonal Lewis Y antibody depletes metastatic breast carcinoma cells from bone marrow. Proc. Am. Soc. Clin. Oncol., 12: 289, 1993.
-
(1993)
Proc. Am. Soc. Clin. Oncol.
, vol.12
, pp. 289
-
-
Schlimok, G.1
Fackler-Schwalbe, I.2
Pantel, K.3
Loibner, H.4
Riethmüller, G.5
-
15
-
-
0029925934
-
Treatment of advanced solid tumors with immunotoxin LMB-1: An antibody linked to Pseudomanas exotoxin
-
Pai, L. H., Wittes, R., Setser A., Willingham M. C., and Pastan, I. Treatment of advanced solid tumors with immunotoxin LMB-1: an antibody linked to Pseudomanas exotoxin. Nat. Med., 2: 350-353, 1996.
-
(1996)
Nat. Med.
, vol.2
, pp. 350-353
-
-
Pai, L.H.1
Wittes, R.2
Setser, A.3
Willingham, M.C.4
Pastan, I.5
-
16
-
-
0021236693
-
Determination of immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess
-
Lindmo, T., Boven, E., Cuttitta, F., Fedorko, J., and Bunn, P. A. Determination of immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J. Immunol. Methods, 72: 77-89, 1984.
-
(1984)
J. Immunol. Methods
, vol.72
, pp. 77-89
-
-
Lindmo, T.1
Boven, E.2
Cuttitta, F.3
Fedorko, J.4
Bunn, P.A.5
-
17
-
-
0029587051
-
Preparation and preclinical evaluation of humanized A33 immunoconjugates for radioimmunotherapy
-
King, D. J., Antoniw, P., Owens, R. J., Adair, J. R., Haines, A. M. R., Farnsworth, A. P. H., Finney, H., Lawson, A. D. G., Lyons, A., Baker, T. S., Baldock, D., Mackintosh, J., Gofton, C., Yarranton, G. T., McWilliams, W., Shochat, D., Leichner, P. H., Welt, S., Old, L. J., and Mountain, A. Preparation and preclinical evaluation of humanized A33 immunoconjugates for radioimmunotherapy. Br. J. Cancer, 72: 1364-1372, 1995.
-
(1995)
Br. J. Cancer
, vol.72
, pp. 1364-1372
-
-
King, D.J.1
Antoniw, P.2
Owens, R.J.3
Adair, J.R.4
Haines, A.M.R.5
Farnsworth, A.P.H.6
Finney, H.7
Lawson, A.D.G.8
Lyons, A.9
Baker, T.S.10
Baldock, D.11
Mackintosh, J.12
Gofton, C.13
Yarranton, G.T.14
McWilliams, W.15
Shochat, D.16
Leichner, P.H.17
Welt, S.18
Old, L.J.19
Mountain, A.20
more..
-
18
-
-
0022558297
-
Replacing the complementarity-determining regions in a human antibody with those from a mouse
-
Jones, P. T., Dear, P. H., Foote J., Neuberger, M. S., and Winter G. Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature (Lond.), 321: 522-525, 1986.
-
(1986)
Nature (Lond.)
, vol.321
, pp. 522-525
-
-
Jones, P.T.1
Dear, P.H.2
Foote, J.3
Neuberger, M.S.4
Winter, G.5
-
19
-
-
8944243547
-
High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice
-
Fishwild, D. M., O'Donnell, S. L., Bengoechea, T., Hudson, D. V., Harding, F., Bernhard, S. L., Jones, D., Kay, R. M., Higgins, K. M., Schramm, S. R., and Lonberg, N. High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice. Nat. Biotechnol., 14: 845-851, 1996.
-
(1996)
Nat. Biotechnol.
, vol.14
, pp. 845-851
-
-
Fishwild, D.M.1
O'Donnell, S.L.2
Bengoechea, T.3
Hudson, D.V.4
Harding, F.5
Bernhard, S.L.6
Jones, D.7
Kay, R.M.8
Higgins, K.M.9
Schramm, S.R.10
Lonberg, N.11
-
20
-
-
0003404076
-
Humanized anti-Lewis Y antibodies: In vitro properties and pharmacokinetics in rhesus monkeys
-
Co, M. S., Baker, J., Bedenarik, K., Janzek, E., Neruda, W., Mayer, P., Plot, R., Stumper, B., Vasquez, M., Queen, C., and Loibner H., Humanized anti-Lewis Y antibodies: in vitro properties and pharmacokinetics in rhesus monkeys. Cancer Res., 56: 1118-1125, 1996.
-
(1996)
Cancer Res.
, vol.56
, pp. 1118-1125
-
-
Co, M.S.1
Baker, J.2
Bedenarik, K.3
Janzek, E.4
Neruda, W.5
Mayer, P.6
Plot, R.7
Stumper, B.8
Vasquez, M.9
Queen, C.10
Loibner, H.11
-
21
-
-
0032109038
-
Monoclonal antibody production: Problems and solutions
-
Falkenberg, F. W. Monoclonal antibody production: problems and solutions. Res. Immunol, 149: 542-547, 1998.
-
(1998)
Res. Immunol
, vol.149
, pp. 542-547
-
-
Falkenberg, F.W.1
-
22
-
-
0033119556
-
Instrumental biosensors: New perspectives for the analysis of biomolecular interactions
-
Nice, E. C., and Catimel, B. Instrumental biosensors: new perspectives for the analysis of biomolecular interactions. Bioessays, 21: 339-352, 1999.
-
(1999)
Bioessays
, vol.21
, pp. 339-352
-
-
Nice, E.C.1
Catimel, B.2
-
23
-
-
0030266707
-
Multivalent antibody fragments with high functional affinity for a tumour-associated carbohydrate antigen
-
Rheinnecker, M., Hardt, C., Ilag, L. L., Kufer, P., Gruber, R., Hoess, A., Lupas, A., Rottenberger, C., Pluckthun, A., and Pack, P. Multivalent antibody fragments with high functional affinity for a tumour-associated carbohydrate antigen. J. Immunol., 157: 2989-2997, 1996.
-
(1996)
J. Immunol.
, vol.157
, pp. 2989-2997
-
-
Rheinnecker, M.1
Hardt, C.2
Ilag, L.L.3
Kufer, P.4
Gruber, R.5
Hoess, A.6
Lupas, A.7
Rottenberger, C.8
Pluckthun, A.9
Pack, P.10
-
24
-
-
0029991439
-
HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer
-
HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J. Clin. Oncol., 14: 737-744, 1996.
-
(1996)
J. Clin. Oncol.
, vol.14
, pp. 737-744
-
-
Baselga, J.1
Tripathy, D.2
Mendelsohn, J.3
Baughman, S.4
Benz, C.C.5
Dantis, L.6
Sklarin, N.T.7
Seidman, A.S.8
Hudis, C.A.9
Moore, J.10
Rosen, P.P.11
Twaddell, T.12
Henderson, I.C.13
Norton, L.14
-
25
-
-
0031903646
-
Phase II study of receptor-enhanced chemosensilivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment
-
Pegram, M. D., Lipton, A., Hayes, D. F., Weber, B. L., Baselga, J. M., Tripathy, D., Baly, D., Baughman, S. A., Twaddell, T., Glaspy, J. A., and Slamon, D. J. Phase II study of receptor-enhanced chemosensilivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. J. Clin. Oncol., 16: 2659-2671, 1998.
-
(1998)
J. Clin. Oncol.
, vol.16
, pp. 2659-2671
-
-
Pegram, M.D.1
Lipton, A.2
Hayes, D.F.3
Weber, B.L.4
Baselga, J.M.5
Tripathy, D.6
Baly, D.7
Baughman, S.A.8
Twaddell, T.9
Glaspy, J.A.10
Slamon, D.J.11
-
26
-
-
0028231359
-
A phase IB trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: Specific targeting without immunogenicity
-
Caron, P. C., Jurcic, J. G., Scott, A. M., Finn, R. D., Divgi, C. R., Graham, M. C., Jureidini, I. M., Sgouros, G., Tyson, D., Old, L. J., Larson, S. M., and Scheinberg, D. A. A phase IB trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicity. Blood, 83: 1760-1768, 1994.
-
(1994)
Blood
, vol.83
, pp. 1760-1768
-
-
Caron, P.C.1
Jurcic, J.G.2
Scott, A.M.3
Finn, R.D.4
Divgi, C.R.5
Graham, M.C.6
Jureidini, I.M.7
Sgouros, G.8
Tyson, D.9
Old, L.J.10
Larson, S.M.11
Scheinberg, D.A.12
-
27
-
-
0029658878
-
111indium-labeled engineered human antibody CTMO1 in ovarian cancer patients: Influence of protein dose
-
111indium-labeled engineered human antibody CTMO1 in ovarian cancer patients: influence of protein dose. Cancer Res, 56: 5179-5185, 1996.
-
(1996)
Cancer Res
, vol.56
, pp. 5179-5185
-
-
Van Hof, A.C.1
Molthoff, C.F.M.2
Davies, Q.3
Perkins, A.C.4
Verheijen, R.H.M.5
Kenemans, P.6
Den Hollander, W.7
Wilhelm, A.J.8
Baker, T.S.9
Sopwith, M.10
Frier, M.11
Symonds, E.M.12
Roos, J.C.13
-
28
-
-
0000344518
-
Phase I study of humanized A33 (huA33) antibody in patients with advanced colorectal carcinoma
-
Welt, S., Ritter, G., Cohen, L., Williams, C. J., Dantis, L., Richards, E. C., Kemeny, N., and Old, L. J. Phase I study of humanized A33 (huA33) antibody in patients with advanced colorectal carcinoma. Proc. Am. Soc. Clin. Oncol., 16: 436a, 1997.
-
(1997)
Proc. Am. Soc. Clin. Oncol.
, vol.16
-
-
Welt, S.1
Ritter, G.2
Cohen, L.3
Williams, C.J.4
Dantis, L.5
Richards, E.C.6
Kemeny, N.7
Old, L.J.8
|